Meta in charts: R&D expenses rise 46% to $17.7B in Q1

Meta’s Q1 results show steep spending increases that pressured the stock: R&D (and capex) surged, with R&D up 46% to about $17.7 billion, and management’s guidance/capex outlook was described as lackluster. The market reacted negatively — the page shows a pre-close quote near $669 and a post-market print around $622 (about -6.9%), and commentary says investors were spooked by higher investment and muted guidance. Charts on ARPP and daily active people were included, but the headline market impact is investor concern over rising costs and capital intensity, weighing on Meta shares in after-hours trading.